|
1
|
Takeuchi A, Tsuchiya H, Ishii T, Nishida
Y, Abe S, Matsumine A, Kawai A, Yoshimura K and Ueda T: Clinical
outcome of recurrent giant cell tumor of the extremity in the era
before molecular target therapy: The Japanese musculoskeletal
oncology group study. BMC Musculoskelet Disord. 17:3062016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Athanasou NA, Bansal M, Forsyth R, Reid RP
and Sapi Z: Tumours of soft tissue and bone. Pathology and
Genetics. World Health Organization Classification of Tumours.
Bridge J, Hogendoorn P and Mertens F: IARC press; 2013
|
|
3
|
Viswanathan S and Jambhekar NA: Metastatic
giant cell tumor of bone: Are there associated factors and best
treatment modalities? Clin Orthop Relat Res. 468:827–833. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Derbel O and Blay JY: Giant cell tumors of
bone. Bone Cancer. Elsevier; pp. 437–445. 2015, View Article : Google Scholar
|
|
5
|
Atkins GJ, Kostakis P, Vincent C, Farrugia
AN, Houchins JP, Findlay DM, Evdokiou A and Zannettino AC: RANK
expression as a cell surface marker of human osteoclast precursors
in peripheral blood, bone marrow, and giant cell tumors of bone. J
Bone Miner Res. 21:1339–1349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anazawa U, Hanaoka H, Shiraishi T, Morioka
H, Morii T and Toyama Y: Similarities between giant cell tumor of
bone, giant cell tumor of tendon sheath, and pigmented villonodular
synovitis concerning ultrastructural cytochemical features of
multinucleated giant cells and mononuclear stromal cells.
Ultrastruct Pathol. 30:151–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lindeman JH, Hanemaaijer R, Mulder A,
Dijkstra PDS, Szuhai K, Bromme D, Verheijen JH and Hogendoorn PCW:
Cathepsin K is the principal protease in giant cell tumor of bone.
Am J Pathol. 165:593–600. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kotake S, Sato K, Kim KJ, Takahashi N,
Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T and
Kashiwazaki S: Interleukin-6 and soluble interleukin-6 receptors in
the synovial fluids from rheumatoid arthritis patients are
responsible for osteoclast-like cell formation. J Bone Miner Res.
11:88–95. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Collier FM, Huang WH, Holloway WR, Hodge
JM, Gillespie MT, Daniels LL, Zheng MH and Nicholson GC:
Osteoclasts from human giant cell tumors of bone lack estrogen
receptors. Endocrinology. 139:1258–1267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huvos AG: Tumors of histiocytic or
fibrohistiocytic origin: Giant cell tumor of bone. Bone Tumors:
Diagnosis, Treatment, and Prognosis. 2nd edition. Huvos AG: WB
Saunders; pp. 429–467. 1991
|
|
11
|
Kim TS and Park JS: Metastasising
recurrent giant cell tumor: A case report. J Korean Bone Joint
Tumor Soc. 7:73–79. 2001.
|
|
12
|
Mirra JM: Giant cell tumors. Bone Tumors;
Clinical Radiological, and Pathologic Correlations. Mirra JM: Lea
and Febiger; pp. 941–1020. 1989
|
|
13
|
Osaka S, Sugita H, Osaka E, Yoshida Y, Ryu
J, Hemmi A and Suzuki K: Clinical and immunohistochemical
characteristics of benign giant cell tumour of bone with pulmonary
metastases: Case series. J Orthop Surg (Hong Kong). 12:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Benevenia J, Patterson FR, Beebe KS,
Abdelshahed MM and Uglialoro AD: Comparison of phenol and argon
beam coagulation as adjuvant therapies in the treatment of stage 2
and 3 benign-aggressive bone tumors. Orthopedics. 35:e371–e378.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deventer N, Budny T, Gosheger G, Rachbauer
A, Puetzler J, Theil JC, Kovtun D, de Vaal M and Deventer N: Giant
cell tumor of bone: A single center study of 115 cases. J Bone
Oncol. 33:1004172022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benevenia J, Rivero SM, Moore J, Ippolito
JA, Siegerman DA, Beebe KS and Patterson FR: Supplemental bone
grafting in giant cell tumor of the extremity reduces nononcologic
complications. Clin Orthop Relat Res. 475:776–783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Campanacci M, Baldini N, Boriani S and
Sudanese A: Giant-cell tumor of bone. J Bone Joint Surg Am.
69:106–114. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Balke M, Schremper L, Gebert C, Ahrens H,
Streitbuerger A, Koehler G, Hardes J and Gosheger G: Giant cell
tumor of bone: Treatment and outcome of 214 cases. J Cancer Res
Clin Oncol. 134:969–978. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abat F, Almenara M, Peiró A, Trullols L,
Bagué S and Grácia I: Giant cell tumor of bone: A series of 97
cases with a mean follow-up of 12 years. Rev Esp Cir Ortop
Traumatol. 59:59–65. 2015.(In Spanish). PubMed/NCBI
|
|
20
|
Thomas D, Henshaw R, Skubitz K, Chawla S,
Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, et al:
Denosumab in patients with giant-cell tumour of bone: An
open-label, phase 2 study. Lancet Oncol. 11:275–280. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian R, Su M, Tian Y, Li F, Li L, Kuang A
and Zeng J: Dual-time point PET/CT with F-18 FDG for the
differentiation of malignant and benign bone lesions. Skeletal
Radiol. 38:451–458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cowan RW and Singh G: Giant cell tumor of
bone: A basic science perspective. Bone. 52:238–246. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Graziano V and De Laurenzi V: Role of p63
in cancer development. Biochim Biophys Acta. 1816:57–66.
2011.PubMed/NCBI
|
|
24
|
Babeto E, Conceição AL, Valsechi MC, Peitl
Junior P, de Campos Zuccari DA, de Lima LG, Bonilha JL, de Freitas
Calmon M, Cordeiro JA and Rahal P: Differentially expressed genes
in giant cell tumor of bone. Virchows Arch. 458:467–476. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsukamoto S, Ciani G, Mavrogenis AF,
Ferrari C, Akahane M, Tanaka Y, Rocca M, Longhi A and Errani C:
Outcome of lung metastases due to bone giant cell tumor initially
managed with observation. J Orthop Surg Res. 15:5102020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dominkus M, Ruggieri P, Bertoni F,
Briccoli A, Picci P, Rocca M and Mercuri M: Histologically verified
lung metastases in benign giant cell tumours-14 cases from a single
institution. Int Orthop. 30:499–504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jacopin S, Viehweger E, Glard Y, Launay F,
Jouve JL, Bouvier C and Bollini G: Fatal lung metastasis secondary
to index finger giant cell tumor in an 8-year-old child. Orthop
Traumatol Surg Res. 96:310–313. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nemes S, Jonasson JM, Genell A and
Steineck G: Bias in odds ratios by logistic regression modelling
and sample size. BMC Med Res Methodol. 9:562009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
van Smeden M, Moons KGM, de Groot JAH,
Collins GS, Altman DG, Eijkemans MJC and Reitsma JB: Sample size
for binary logistic prediction models: Beyond events per variable
criteria. Stat Methods Med Res. 28:2455–2474. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pavlou M, Ambler G, Seaman S, De Iorio M
and Omar RZ: Review and evaluation of penalised regression methods
for risk prediction in low-dimensional data with few events. Stat
Med. 35:1159–1177. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
King G and Zeng L: Logistic regression in
rare events data. Polit Anal. 9:137–163. 2001. View Article : Google Scholar
|
|
32
|
Altman DG, Gore SM, Gardner MJ and Pocock
SJ: Statistical guidelines for contributors to medical journals. Br
Med J (Clin Res Ed). 286:1489–1493. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Errani C, Ruggieri P, Asenzio MA, Toscano
A, Colangeli S, Rimondi E, Rossi G, Longhi A and Mercuri M: Giant
cell tumor of the extremity: A review of 349 cases from a single
institution. Cancer Treat Rev. 36:1–7. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kremen TJ Jr, Bernthal NM, Eckardt MA and
Eckardt JJ: Giant cell tumor of bone: Are we stratifying results
appropriately? Clin Orthop Relat Res. 470:677–683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takeuchi A, Tsuchiya H, Niu X, Ueda T,
Jeon DG, Wang EH, Asavamongkolkul A, Kusuzaki K, Sakayama K and
Kang YK: The prognostic factors of recurrent GCT: A cooperative
study by the Eastern Asian musculoskeletal oncology group. J Orthop
Sci. 16:196–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Klenke FM, Wenger DE, Inwards CY, Rose PS
and Sim FH: Recurrent giant cell tumor of long bones: Analysis of
surgical management. Clin Orthop Relat Res. 469:1181–1187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Donthineni R, Boriani L, Ofluoglu O and
Bandiera S: Metastatic behaviour of giant cell tumour of the spine.
Int Orthop. 33:497–501. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Faisham WI, Zulmi W, Halim AS, Biswal BM,
Mutum SS and Ezane AM: Aggressive giant cell tumour of bone.
Singapore Med J. 47:679–683. 2006.PubMed/NCBI
|
|
39
|
Prosser GH, Baloch KG, Tillman RM, Carter
SR and Grimer RJ: Does curettage without adjuvant therapy provide
low recurrence rates in giant-cell tumors of bone? Clin Orthop
Relat Res. 211–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Su YP, Chen WM and Chen TH: Giant-cell
tumors of bone: An analysis of 87 cases. Int Orthop. 28:239–243.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Trieb K, Bitzan P, Lang S, Dominkus M and
Kotz R: Recurrence of curetted and bone-grafted giant-cell tumours
with and without adjuvant phenol therapy. Eur J Surg Oncol.
27:200–202. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Blackley HR, Wunder JS, Davis AM, White
LM, Kandel R and Bell RS: Treatment of giant-cell tumors of long
bones with curettage and bone-grafting. J Bone Joint Surg Am.
81:811–820. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
O'Donnell RJ, Springfield DS, Motwani HK,
Ready JE, Gebhardt MC and Mankin HJ: Recurrence of giant-cell
tumors of the long bones after curettage and packing with cement. J
Bone Joint Surg Am. 76:1827–1833. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kay RM, Eckardt JJ, Seeger LL, Mirra JM
and Hak DJ: Pulmonary metastasis of benign giant cell tumor of
bone. Six histologically confirmed cases, including one of
spontaneous regression. Clin Orthop Relat Res. 219–230.
1994.PubMed/NCBI
|
|
45
|
Rock MG, Pritchard DJ and Unni KK:
Metastases from histologically benign giant-cell tumor of bone. J
Bone Joint Surg Am. 66:269–274. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Goldenberg RR, Campbell CJ and Bonfiglio
M: Giant-cell tumor of bone. An analysis of two hundred and
eighteen cases. J Bone Joint Surg Am. 52:619–664. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang J, Liu X, Yang Y, Yang R, Tang X, Yan
T and Guo W: Pulmonary metastasis of giant cell tumour: A
retrospective study of three hundred and ten cases. Int Orthop.
45:769–778. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chan CM, Adler Z, Reith JD and Gibbs CP
Jr: Risk factors for pulmonary metastases from giant cell tumor of
bone. J Bone Joint Surg Am. 97:420–428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ebeid WA, Badr IT, Mesregah MK and Hasan
BZ: Risk factors and oncological outcomes of pulmonary metastasis
in patients with giant cell tumor of bone. J Clin Orthop Trauma.
20:1014992021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Errani C, Tsukamoto S, Ciani G and Donati
DM: Present day controversies and consensus in curettage for giant
cell tumor of bone. J Clin Orthop Trauma. 10:1015–1020. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kito M, Matusmoto S, Ae K, Tanizawa T,
Gokita T, Kobayashi H, Hayakawa K and Funauchi Y: Pulmonary
metastasis from giant cell tumor of bone: Clinical outcome prior to
the introduction of molecular target therapy. Jpn J Clin Oncol.
47:529–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen CC, Liau CT, Chang CH, Hsu YH and
Shih HN: Giant cell tumors of the bone with pulmonary metastasis.
Orthopedics. 39:e68–e73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dufresne A, Derbel O, Cassier P, Vaz G,
Decouvelaere AV and Blay JY: Giant-cell tumor of bone, anti-RANKL
therapy. Bonekey Rep. 1:1492012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Demirsoy U, Karadogan M, Selek Ö, Anik Y,
Aksu G, Müezzinoglu B and Corapcioglu F: Golden bullet-denosumab:
Early rapid response of metastatic giant cell tumor of the bone. J
Pediatr Hematol Oncol. 36:156–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mak IWY, Evaniew N, Popovic S, Tozer R and
Ghert M: A translational study of the neoplastic cells of giant
cell tumor of bone following neoadjuvant denosumab. J Bone Joint
Surg Am. 96:e1272014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kumar A, Sinha S, Haider Y, Jameel J and
Kumar S: Role of zoledronic acid supplementation in reducing
post-surgical recurrence of giant cell tumor of bone: A
meta-analysis of comparative studies. Cureus.
13:e167422021.PubMed/NCBI
|
|
57
|
Li H, Gao J, Gao Y, Lin N, Zheng M and Ye
Z: Denosumab in giant cell tumor of bone: Current status and
pitfalls. Front Oncol. 10:5806052020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Siebenrock KA, Unni KK and Rock MG:
Giant-cell tumour of bone metastasising to the lungs. A long-term
follow-up. J Bone Joint Surg Br. 80:43–47. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Muheremu A and Niu X: Pulmonary metastasis
of giant cell tumor of bones. World J Surg Oncol. 12:2612014.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Borkowska AM, Szumera-Ciećkiewicz A,
Szostakowski B, Pieńkowski A and Rutkowski PL: Denosumab in giant
cell tumor of bone: Multidisciplinary medical management based on
pathophysiological mechanisms and real-world evidence. Cancers
(Basel). 14:22902022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
van der Heijden L, Dijkstra S, van de
Sande M and Gelderblom H: Current concepts in the treatment of
giant cell tumour of bone. Curr Opin Oncol. 32:332–338. 2020.
View Article : Google Scholar : PubMed/NCBI
|
